
zzso zzso of the zzso A exhibit potent zzso activity yet do not mediate appreciable zzso or zzso toxicity in both animal models and cancer zzso zzso zzso the first zzso being evaluated as a therapeutic in humans, has progressed to phase III clinical trials in patients with zzso zzso zzso of zzso to zzso zzso zzso zzso was shown to enhance specific cell killing by several orders of magnitude both in zzso and in animal zzso In this review we describe the development and current status of genetically engineered zzso generation zzso as promising novel zzso zzso 

